RxDoctor Payments Data

Adnan Danish, MD

Radiation Oncology · Wayne, NJNPI 1265440903

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (40.5%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 36 manufacturers reported payments, led by GT Medical Technologies, Inc at 38.2% of the total. Reporting peaked in 2022 at $17,031 and has fallen 59.3% since, to $6,934 in 2025. Among radiation oncology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$44,603in general payments, 2019–2025

Across 176 payments — averaging $253.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GT Medical Technologies, Inc$17K
  • Reflexion Medical, Inc.$10K
  • Bioprotect Medical, Inc.$6K
  • Elekta, Inc.$3K
  • Novocure Inc.$2K
  • Palette Life Sciences, Inc.$2K
  • plus $4K from 30 others
$9,312in research payments, 2019–2025

Across 1 payment — averaging $9312.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Reflexion Medical, Inc.$9K

What the payments were for

  • Consulting fees$18,07541%
  • Speaking & faculty fees$9,76022%
  • Travel & lodging$7,19416%
  • Food & beverage$9,34921%
  • Education$2040%
  • Entertainment$200%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$44,603 in reported general payments places this provider in the 95th percentile of 132 radiation oncology providers in New Jersey.

See all radiation oncology providers in New Jersey

Medicare billing

Part B allowed, 2024
$243,571
Medicare patients
85
Services billed
1,624

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl38$518
CefuroximeCefuroxime Axetil16$92
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen20$65
Lorazepam16$8

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Wayne

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →